{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T20:46:08Z","timestamp":1772225168032,"version":"3.50.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T00:00:00Z","timestamp":1143849600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["HNO"],"published-print":{"date-parts":[[2006,4]]},"DOI":"10.1007\/s00106-005-1318-y","type":"journal-article","created":{"date-parts":[[2005,8,25]],"date-time":"2005-08-25T14:23:37Z","timestamp":1124979817000},"page":"277-286","source":"Crossref","is-referenced-by-count":14,"title":["Einfluss eines ML-1-normierten Mistelextraktes auf die Lebensqualit\u00e4t bei Patienten mit Kopf-Hals-Karzinomen","Influence of ML-1 standardized mistletoe extract on the quality of life in head and neck cancer patients"],"prefix":"10.1007","volume":"54","author":[{"given":"M. K.","family":"Steuer-Vogt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Bonkowsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Scholz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Fauser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Licht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Ambrosch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"1318_CR1","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S1368-8375(01)00031-8","volume":"38","author":"Allison","year":"2002","unstructured":"Allison PJ (2002) Alcohol consumption is associated with improved health-related quality of life in head and neck cancer patients. Oral Oncol 38: 81\u201386","journal-title":"Oral Oncol"},{"key":"1318_CR2","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1023\/A:1008931906253","volume":"9","author":"Allison","year":"2000","unstructured":"Allison PJ, Guichard C, Gilain L (2000) A prospective investigation of dispositional optimism as a predictor of health-related quality of life in head and neck cancer patients. Qual Life Res 9: 951\u2013960","journal-title":"Qual Life Res"},{"key":"1318_CR3","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1023\/A:1008880816543","volume":"7","author":"Allison","year":"1998","unstructured":"Allison PJ, Locker D, Wood-Dauphinee S, Black M, Feine JS (1998) Correlates of health-related quality of life in upper aerodigestive tract cancer patients. Qual Life Res 7: 713\u2013722","journal-title":"Qual Life Res"},{"key":"1318_CR4","unstructured":"Barofsky I (1996) Cancer: Psychological aspects. In: Spilker B (ed) Quality of life and pharmaeconomics in clinical trials. Lippincott-Raven, Philadelphia, pp\u00a0993\u20131002"},{"key":"1318_CR5","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1055\/s-2001-12100","volume":"126","author":"Berg","year":"2001","unstructured":"Berg PA, Stein GM (2001) Does mistletoe therapy influence the defense against epithelial tumors? A critical immunologic analysis. Dtsch Med Wochenschr 126: 339\u2013345","journal-title":"Dtsch Med Wochenschr"},{"key":"1318_CR6","unstructured":"Beuth J, Stoffel B, Ko HL, Jeljaszewicz J, Pulverer G (1995) Immunomodulating ability of galactoside-specific lectin standardized and depleted mistletoe extract. Arzneimittelforschung. 45: 1240\u20131242"},{"key":"1318_CR7","first-page":"29","volume":"5","author":"Beuth","year":"1991","unstructured":"Beuth J, Ko HL, Gabius HJ, Pulverer G (1991) Influence of treatment with the immunomodulatory effective dose of the beta-galactoside-specific lectin from mistletoe on tumor colonization in BALB\/c-mice for two experimental model systems. In Vivo 5: 29\u201332","journal-title":"In Vivo"},{"key":"1318_CR8","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1016\/S0959-8049(00)00186-6","volume":"36","author":"Bjordal","year":"2000","unstructured":"Bjordal K, de Graeff A, Fayers PM et al. (2000) A 12 country field study of the EORTC QLQ-C30 (version 3.0) and the head and neck cancer specific module (EORTC QLQ-H&N35) in head and neck patients. EORTC Quality of Life Group. Eur J Cancer 36: 1796\u2013807","journal-title":"Eur J Cancer"},{"key":"1318_CR9","first-page":"4187","volume":"22","author":"Braun","year":"2002","unstructured":"Braun JM, Ko HL, Schierholz JM, Beuth J (2002) Standardized mistletoe extract augments immune response and down-regulates local and metastatic tumor growth in murine models. Anticancer Res 22: 4187\u20134190","journal-title":"Anticancer Res"},{"key":"1318_CR10","first-page":"210","volume":"11","author":"Bullinger","year":"1996","unstructured":"Bullinger M (1996) Methoden zur Lebensqualit\u00e4tsbewertung in der Onkologie. Forum DKG 11: 210\u2013218","journal-title":"Forum DKG"},{"key":"1318_CR11","unstructured":"Edler L (2004) Mistel in der Krebstherapie: Fragw\u00fcrdige Ergebnisse neuerer klinischer Studien. Dtsch \u00c4rztebl 101: B39-B44"},{"key":"1318_CR12","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/ijc.11386","volume":"107","author":"Ernst","year":"2003","unstructured":"Ernst E, Schmidt K, Steuer-Vogt MK (2003) Mistletoe for cancer? A systematic review of randomized clinical trials. Int J Cancer 107: 262\u2013267","journal-title":"Int J Cancer"},{"key":"1318_CR13","unstructured":"Fayers P, Aaronson NK, Bjordal K, Sullivan M (1995) EORTC QLQ-C30 Scoring Manual. EORTC Study Group on Quality of Life, pp\u00a01\u201346"},{"key":"1318_CR14","first-page":"915","volume":"16","author":"Friess","year":"1996","unstructured":"Friess H, Beger HG, Kunz J, Funk N, Schilling M, B\u00fcchler MW (1996) Treatment of advanced pancreatic cancer with mistletoe: results of a pilot trial. Anticancer Res 16: 915\u2013920","journal-title":"Anticancer Res"},{"key":"1318_CR15","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1055\/s-2007-1024099","volume":"123","author":"Grothey","year":"1998","unstructured":"Grothey A, D\u00fcppe J, Hasenburg A, Voigtmann R (1998) Use of alternative medicine in oncology patients. Dtsch Med Wochenschr 123: 923\u2013929","journal-title":"Dtsch Med Wochenschr"},{"key":"1318_CR16","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1097\/00005537-200104000-00021","volume":"111","author":"Hammerlid","year":"2001","unstructured":"Hammerlid E, Bjordal K, Ahlner-Elmqvist M et al. (2001) A prospective study of quality of life in head and neck cancer patients. Part I: at diagnosis. Laryngoscope 111: 669\u2013680","journal-title":"Laryngoscope"},{"key":"1318_CR17","first-page":"1","volume":"12","author":"Heiny","year":"1991","unstructured":"Heiny BM (1991) Additive Therapie mit standardisiertem Mistelextrakt reduziert die Leukopenie und verbessert die Lebensqualit\u00e4t von Patientinnen mit fortgeschrittenem Mammakarzinom unter palliativer Chemotherapie (VEC-Schema). Krebsmedizin 12: 1\u201314","journal-title":"Krebsmedizin"},{"key":"1318_CR18","first-page":"419","volume":"48","author":"Heiny","year":"1997","unstructured":"Heiny BM, Albrecht V (1997) Komplement\u00e4re Therapie mit Mistellektin-1-normiertem Extrakt. Lebensqualit\u00e4tsstabilisierung beim fortgeschrittenen kolorektalen Karzinom \u2014 Fakt oder Fiktion? Med Welt 48: 419\u2013423","journal-title":"Med Welt"},{"key":"1318_CR19","doi-asserted-by":"crossref","unstructured":"Joshi SS, Komanduri KC, Gabius S, Gabius HJ (1991) Immunotherapeutic effects of purified mistletoe lectin (ML-1) on murine large lymphoma. In: Gabius HJ, Gabius S (eds) Lectins and cancer. Springer, Berlin Heidelberg New York, pp\u00a0207\u2013216","DOI":"10.1007\/978-3-642-76739-5_14"},{"key":"1318_CR20","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s001060100550","volume":"50","author":"Maune","year":"2002","unstructured":"Maune S, Bosse F, Heissenberg MC, Schmidt C, Berens M, Kuchler T (2002) A concept for the assessment of quality of life in patients with carcinomas of the upper aerodigestive tract. HNO 50: 347\u2013353","journal-title":"HNO"},{"key":"1318_CR21","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s005200050175","volume":"6","author":"Miller","year":"1998","unstructured":"Miller M, Boyer MJ, Butow PN, Gattellari M, Dunn SM, Childs A (1998) The use of unproven methods of treatment by cancer patients. Frequency, expectations and cost. Support Care Cancer 6: 337\u2013347","journal-title":"Support Care Cancer"},{"key":"1318_CR22","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1023\/A:1026429831234","volume":"6","author":"Osoba","year":"1997","unstructured":"Osoba D, Aaronson N, Zee B, Sprangers M, te VA (1997) Modification of the EORTC QLQ-C30 (version 2.0) based on content validity and reliability testing in large samples of patients with cancer. The Study Group on Quality of Life of the EORTC and the Symptom Control and Quality of Life Committees of the NCI of Canada Clinical Trials Group. Qual Life Res 6: 103\u2013108","journal-title":"Qual Life Res"},{"key":"1318_CR23","unstructured":"Spilker B (1996) Introduction to the field of quality of life trials. In: Spilker B, ed.Quality of life and pharmaeconomics in clinical trials. Lippincott-Raven, Philadelphia, pp\u00a01\u201310"},{"key":"1318_CR24","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1211\/fact.2004.00006","volume":"9","author":"Steuer-Vogt","year":"2004","unstructured":"Steuer-Vogt MK (2004) Mistletoe is a useful adjunct in cancer therapy \u2014 Contra part. Focus Altern Complement Ther 9: 15\u201318","journal-title":"Focus Altern Complement Ther"},{"key":"1318_CR25","unstructured":"Steuer-Vogt MK, Bonkowsky V, Scholz M, Arnold W (2002) Plattenepithelkarzinome des Kopf-Hals-Bereichs. Mistellektin-1-normierte Viscumtherapie. Dtsch \u00c4rztebl 46: B2585\u2013B2591"},{"key":"1318_CR26","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0959-8049(00)00360-9","volume":"37","author":"Steuer-Vogt","year":"2001","unstructured":"Steuer-Vogt MK, Bonkowsky V, Ambrosch P et al. (2001) The effect of an adjuvant mistletoe treatment programme in resected head and neck cancer patients. a randomised controlled clinical trial. Eur J Cancer 37: 23\u201331","journal-title":"Eur J Cancer"}],"container-title":["HNO"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00106-005-1318-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00106-005-1318-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00106-005-1318-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,4]],"date-time":"2023-05-04T08:50:31Z","timestamp":1683190231000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00106-005-1318-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,4]]}},"alternative-id":["1318"],"URL":"https:\/\/doi.org\/10.1007\/s00106-005-1318-y","relation":{},"ISSN":["0017-6192","1433-0458"],"issn-type":[{"value":"0017-6192","type":"print"},{"value":"1433-0458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,4]]}}}